BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kondratova M, Czerwinska U, Sompairac N, Amigorena SD, Soumelis V, Barillot E, Zinovyev A, Kuperstein I. A multiscale signalling network map of innate immune response in cancer reveals cell heterogeneity signatures. Nat Commun 2019;10:4808. [PMID: 31641119 DOI: 10.1038/s41467-019-12270-x] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 6.0] [Reference Citation Analysis]
Number Citing Articles
1 Saleh R, Sasidharan Nair V, Al-Dhaheri M, Khawar M, Abu Nada M, Alajez NM, Elkord E. RNA-Seq Analysis of Colorectal Tumor-Infiltrating Myeloid-Derived Suppressor Cell Subsets Revealed Gene Signatures of Poor Prognosis. Front Oncol 2020;10:604906. [PMID: 33312958 DOI: 10.3389/fonc.2020.604906] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
2 van Leent MMT, Priem B, Schrijver DP, de Dreu A, Hofstraat SRJ, Zwolsman R, Beldman TJ, Netea MG, Mulder WJM. Regulating trained immunity with nanomedicine. Nat Rev Mater. [DOI: 10.1038/s41578-021-00413-w] [Reference Citation Analysis]
3 Jiang H, Yu D, Yang P, Guo R, Kong M, Gao Y, Yu X, Lu X, Fan X. Revealing the transcriptional heterogeneity of organ‐specific metastasis in human gastric cancer using single‐cell RNA Sequencing. Clinical & Translational Med 2022;12. [DOI: 10.1002/ctm2.730] [Reference Citation Analysis]
4 He R, Zang J, Zhao Y, Liu Y, Ruan S, Zheng X, Chong G, Xu D, Yang Y, Yang Y, Zhang T, Gu J, Dong H, Li Y. Nanofactory for metabolic and chemodynamic therapy: pro-tumor lactate trapping and anti-tumor ROS transition. J Nanobiotechnology 2021;19:426. [PMID: 34922541 DOI: 10.1186/s12951-021-01169-9] [Reference Citation Analysis]
5 Proaño-vasco A, Baumeister T, Metwaly A, Reitmeier S, Kleigrewe K, Meng C, Gigl M, Engleitner T, Öllinger R, Rad R, Steiger K, Anand A, Strangmann J, Thimme R, Schmid RM, Wang TC, Quante M. High-Fructose Diet Alters Intestinal Microbial Profile and Correlates with Early Tumorigenesis in a Mouse Model of Barrett’s Esophagus. Microorganisms 2021;9:2432. [DOI: 10.3390/microorganisms9122432] [Reference Citation Analysis]
6 Hao Shi, Yan KK, Ding L, Qian C, Chi H, Yu J. Network Approaches for Dissecting the Immune System. iScience 2020;23:101354. [PMID: 32717640 DOI: 10.1016/j.isci.2020.101354] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
7 Marku M, Verstraete N, Raynal F, Madrid-Mencía M, Domagala M, Fournié JJ, Ysebaert L, Poupot M, Pancaldi V. Insights on TAM Formation from a Boolean Model of Macrophage Polarization Based on In Vitro Studies. Cancers (Basel) 2020;12:E3664. [PMID: 33297362 DOI: 10.3390/cancers12123664] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
8 Zhang W, Gao Z, Guan M, Liu N, Meng F, Wang G. ASF1B Promotes Oncogenesis in Lung Adenocarcinoma and Other Cancer Types. Front Oncol 2021;11:731547. [PMID: 34568067 DOI: 10.3389/fonc.2021.731547] [Reference Citation Analysis]
9 Ge Y, Cheng D, Jia Q, Xiong H, Zhang J. Mechanisms Underlying the Role of Myeloid-Derived Suppressor Cells in Clinical Diseases: Good or Bad. Immune Netw 2021;21:e21. [PMID: 34277111 DOI: 10.4110/in.2021.21.e21] [Reference Citation Analysis]
10 Qiu H, Tian W, He Y, Li J, He C, Li Y, Liu N, Li J. Integrated Analysis Reveals Prognostic Value and Immune Correlates of CD86 Expression in Lower Grade Glioma. Front Oncol 2021;11:654350. [PMID: 33954112 DOI: 10.3389/fonc.2021.654350] [Reference Citation Analysis]
11 Cao X, Zhou Y, Mao F, Lin Y, Zhou X, Sun Q. Identification and characterization of three Siglec15-related immune and prognostic subtypes of breast-invasive cancer. International Immunopharmacology 2022;106:108561. [DOI: 10.1016/j.intimp.2022.108561] [Reference Citation Analysis]
12 Lapuente-Santana Ó, Eduati F. Toward Systems Biomarkers of Response to Immune Checkpoint Blockers. Front Oncol 2020;10:1027. [PMID: 32670886 DOI: 10.3389/fonc.2020.01027] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
13 Ackerman SE, Pearson CI, Gregorio JD, Gonzalez JC, Kenkel JA, Hartmann FJ, Luo A, Ho PY, Leblanc H, Blum LK, Kimmey SC, Luo A, Nguyen ML, Paik JC, Sheu LY, Ackerman B, Lee A, Li H, Melrose J, Laura RP, Ramani VC, Henning KA, Jackson DY, Safina BS, Yonehiro G, Devens BH, Carmi Y, Chapin SJ, Bendall SC, Kowanetz M, Dornan D, Engleman EG, Alonso MN. Immune-stimulating antibody conjugates elicit robust myeloid activation and durable antitumor immunity. Nat Cancer 2021;2:18-33. [DOI: 10.1038/s43018-020-00136-x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 3.5] [Reference Citation Analysis]
14 Beatson R, Graham R, Grundland Freile F, Cozzetto D, Kannambath S, Pfeifer E, Woodman N, Owen J, Nuamah R, Mandel U, Pinder S, Gillett C, Noll T, Bouybayoune I, Taylor-Papadimitriou J, Burchell JM. Cancer-associated hypersialylated MUC1 drives the differentiation of human monocytes into macrophages with a pathogenic phenotype. Commun Biol 2020;3:644. [PMID: 33149188 DOI: 10.1038/s42003-020-01359-5] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
15 Farc O, Cristea V. An overview of the tumor microenvironment, from cells to complex networks (Review). Exp Ther Med 2021;21:96. [PMID: 33363607 DOI: 10.3892/etm.2020.9528] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
16 Li G, Wu Z, Gu J, Zhu Y, Zhang T, Wang F, Huang K, Gu C, Xu K, Zhan R, Shen J. Metabolic Signature-Based Subtypes May Pave Novel Ways for Low-Grade Glioma Prognosis and Therapy. Front Cell Dev Biol 2021;9:755776. [PMID: 34888308 DOI: 10.3389/fcell.2021.755776] [Reference Citation Analysis]
17 Koumarianou A, Duran-Moreno J. The Sarcoma Immune Landscape: Emerging Challenges, Prognostic Significance and Prospective Impact for Immunotherapy Approaches. Cancers (Basel) 2021;13:363. [PMID: 33498238 DOI: 10.3390/cancers13030363] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
18 Li B, Zhang B, Wang X, Zeng Z, Huang Z, Zhang L, Wei F, Ren X, Yang L. Expression signature, prognosis value, and immune characteristics of Siglec-15 identified by pan-cancer analysis. Oncoimmunology 2020;9:1807291. [PMID: 32939323 DOI: 10.1080/2162402X.2020.1807291] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 2.5] [Reference Citation Analysis]
19 Delplace F, Huard-Chauveau C, Berthomé R, Roby D. Network organization of the plant immune system: from pathogen perception to robust defense induction. Plant J 2021. [PMID: 34399442 DOI: 10.1111/tpj.15462] [Reference Citation Analysis]
20 Kondratova M, Barillot E, Zinovyev A, Calzone L. Modelling of Immune Checkpoint Network Explains Synergistic Effects of Combined Immune Checkpoint Inhibitor Therapy and the Impact of Cytokines in Patient Response. Cancers (Basel) 2020;12:E3600. [PMID: 33276543 DOI: 10.3390/cancers12123600] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
21 Saleh R, Taha RZ, Sasidharan Nair V, Toor SM, Alajez NM, Elkord E. Transcriptomic Profiling of Circulating HLA-DR- Myeloid Cells, Compared with HLA-DR+ Myeloid Antigen-presenting Cells. Immunol Invest 2021;50:952-63. [PMID: 32727251 DOI: 10.1080/08820139.2020.1795875] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]